Sharemaestro company-news research for SeaStar Medical Holding Corporation (ICU), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

NASDAQ United States Insufficient evidence

Company news sentiment

Latest ICU news and sentiment

SeaStar Medical Holding Corporation

Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.

30-day score50Neutral is 50
No directional headline signal 0/100 evidence confidence 0% direct company focus 5 current stories across 0 publishers
Latest weekly closeUSD 3.54week of 18 Sep 2026
Main news subjectEarnings68/100 share of current news
News data statusPartial4 duplicate stories removed

Current company news

No current company-news score

No company-specific headline in the last 30 days currently passes the date and relevance checks. The displayed 50 means no score, not a neutral view.

Observed headline tone50/100 Published 30-day score50/100

Older, less relevant and less reliable stories count for less. Confidence is shown separately.

Latest source headline SeaStar Medical at H.C. Wainwright: adult trial looms over small cap Investing.com ยท 12 Sep 2026 19:07

Available information

Direct evidence

5 current stories are mapped specifically to ICU.

Why there is no score

Too little evidence

The stories agree, but freshness-weighted evidence is only 0.000.

Confidence

Confidence is 0/100, below the threshold for a firm score.

50/100
News scoreNo directional headline signal
0/100
Confidencethin evidence
0%/100
Company news5 company stories
100/100
Story agreement0/100 difference

News history

Daily score and story count over 30 days

Daily weighted evidence
24 Aug: 1 stories25 Aug: 1 stories10 Sep: 2 stories12 Sep: 1 stories 24 Aug: tone 50, 1 stories25 Aug: tone 50, 1 stories10 Sep: tone 50, 2 stories12 Sep: tone 50, 1 stories 95505
22 Aug06 Sep20 Sep
News scoreStory count50 baseline

Confidence

How reliable the score is

Separate from direction

Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.

Amount of evidence0
0.0 after freshness weighting
Source breadth0
0 independent publishers
Company relevance0
share tied directly to this company
Freshness20
recency-weighted evidence
Agreement100
how closely stories agree
Publisher mix0
less reliance on one publisher

Price and news history

Weekly price and news-score history

No current news signal

No sufficiently fresh, directly relevant company news is available for a price comparison.

26 completed price weeks23 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
27 Mar 2026: close 2.74, indexed 100.003 Apr 2026: close 4.31, indexed 157.310 Apr 2026: close 3.71, indexed 135.417 Apr 2026: close 4.2, indexed 153.324 Apr 2026: close 4.13, indexed 150.701 May 2026: close 4.37, indexed 159.508 May 2026: close 4.49, indexed 163.915 May 2026: close 3.95, indexed 144.222 May 2026: close 3.75, indexed 136.929 May 2026: close 3.71, indexed 135.405 Jun 2026: close 2.94, indexed 107.312 Jun 2026: close 2.98, indexed 108.819 Jun 2026: close 3.12, indexed 113.926 Jun 2026: close 3.12, indexed 113.903 Jul 2026: close 4.92, indexed 179.610 Jul 2026: close 4.95, indexed 180.717 Jul 2026: close 4.0, indexed 146.024 Jul 2026: close 3.75, indexed 136.931 Jul 2026: close 3.13, indexed 114.207 Aug 2026: close 3.28, indexed 119.714 Aug 2026: close 3.18, indexed 116.121 Aug 2026: close 3.35, indexed 122.328 Aug 2026: close 3.09, indexed 112.804 Sep 2026: close 2.9799, indexed 108.811 Sep 2026: close 3.03, indexed 110.618 Sep 2026: close 3.54, indexed 129.2 27 Mar 2026: news score 51, close 2.74, 1 stories5103 Apr 2026: news score 50, close 4.31, 1 stories10 Apr 2026: news score 50, close 3.71, 1 stories17 Apr 2026: news score 50, close 4.2, 1 stories08 May 2026: news score 50, close 4.49, 1 stories5015 May 2026: news score 51, close 3.95, 5 stories22 May 2026: news score 51, close 3.75, 5 stories29 May 2026: news score 50, close 3.71, 5 stories05 Jun 2026: news score 50, close 2.94, 4 stories5012 Jun 2026: news score 50, close 2.98, 2 stories26 Jun 2026: news score 51, close 3.12, 5 stories03 Jul 2026: news score 45, close 4.92, 8 stories10 Jul 2026: news score 48, close 4.95, 9 stories4817 Jul 2026: news score 49, close 4.0, 12 stories24 Jul 2026: news score 52, close 3.75, 14 stories31 Jul 2026: news score 54, close 3.13, 22 stories07 Aug 2026: news score 60, close 3.28, 33 stories6014 Aug 2026: news score 50, close 3.18, 47 stories21 Aug 2026: news score 50, close 3.35, 47 stories28 Aug 2026: news score 50, close 3.09, 40 stories04 Sep 2026: news score 50, close 2.9799, 34 stories5011 Sep 2026: news score 50, close 3.03, 12 stories18 Sep 2026: news score 50, close 3.54, 5 stories50 Price index 190.3 140.3 90.3 News score 100 50 0
27 Mar23 Jun18 Sep
Weekly close, indexedSentiment score
26-week price+29.2%latest close 3.54
News score change-1first to latest comparable week
One-week response+16.8%Price confirming higher
Fair-value position-92.9%Below fair value
WeekNews scoreCloseWeekly move
18 Sep 202650USD 3.54+16.8%
11 Sep 202650USD 3.03+1.7%
04 Sep 202650USD 2.9799-3.6%
28 Aug 202650USD 3.09-7.8%
21 Aug 202650USD 3.35+5.3%
14 Aug 202650USD 3.18-3.0%
07 Aug 202660USD 3.28+4.8%
31 Jul 202654USD 3.13-16.5%
Insufficient evidence

News subjects

What is shaping the score

Earnings
Earnings503 stories ยท 60%
Balance sheet501 stories ยท 20%
Market update501 stories ยท 20%

Source mix

Where the evidence comes from

0/100 independence
Investing.com501 stories ยท 20%
Investing.com UK501 stories ยท 20%
GlobeNewswire501 stories ยท 20%
TipRanks501 stories ยท 20%
Market source501 stories ยท 20%

Recurring subjects

Subjects appearing most often

Current evidence
Life Sciences2Financial Markets1Finance1Earnings1

Earlier readings

How the score has changed

38 comparable readings ยท 137 days
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move+050 to 50 ยท Broadly stable
Observed range44โ€“6050 is the neutral baseline
Evidence depth5stories at latest stored reading ยท +4
Confidence0/100Insufficient ยท 0
06 May50 neutral20 Sep 16:11
ConstructiveBalanced or withheldCautious

Changes in the stored score

Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.

ObservedScoreMoveConfidenceStoriesStatus
20 Sep 16:1150+00/100 (-14)5 (-5)Insufficient
12 Sep 23:5950+114/100 (-2)10 (-10)Provisional
10 Sep 23:5949-116/100 (-9)20 (-23)Provisional
25 Aug 23:5950+025/100 (-1)43 (-3)Provisional
24 Aug 23:5950+026/100 (-12)46 (-2)Provisional
17 Aug 23:5950+038/100 (-2)48 (0)Measured
16 Aug 23:5950+040/100 (-3)48 (+1)Measured
15 Aug 23:5950+043/100 (-3)47 (0)Measured

Source headlines

The news behind the score

Showing 1-5 of 5

Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.

#1Not directional
Investing.comDirect company coverageStored article

SeaStar Medical at H.C. Wainwright: adult trial looms over small cap

SeaStar Medical (ICU) presented at the H.C. Wainwright 28th Annual Global Investment Conference, highlighting its pediatric kidney-injury therapy, QUELIMMUNE, and its larger adult acute kidney injury opportunity. The company's stock, which closed at $3.03, is highly volatile, reflecting its early-stage execution and the anticipated outcome of its adult NEUTRALIZE-AKI trial, which is over 65% enrolled. SeaStar Medical aims to transform care for critically ill patients facing organ failure, with significant potential in the adult market.

EarningsFinancial MarketsLife Sciences
Published
12 Sep 2026 19:07
News subject
Earnings
Why this score
The headline reports news without a clear direction
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 7.9d old
Duplicates
1 consolidated
#2Not directional
Investing.com UKDirect company coverageScored from headline

ICU Medical at Wells Fargo conference: focus shifts to cash returns

Published
10 Sep 2026 15:34
News subject
Balance sheet
Why this score
The headline reports news without a clear direction
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 10.0d old
Duplicates
1 consolidated
#3Not directional
GlobeNewswireDirect company coverageStored article

SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference

SeaStar Medical Holding Corporation (Nasdaq: ICU) announced that CEO Eric Schlorff will participate in the HC Wainwright 28th Annual Global Investment Conference from September 14-16, 2026. The company, a commercial-stage healthcare firm, focuses on treatments for critically ill patients with organ failure. Their presentation will be accessible online from September 11, 2026.

FinanceLife Sciences
Published
10 Sep 2026 12:35
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 10.2d old
Duplicates
1 consolidated
#4Not directional
TipRanksDirect company coverageScored from headline

SeaStar Medical Earnings Call Highlights Growth And Risk

Published
25 Aug 2026 00:45
News subject
Earnings
Why this score
The headline reports news without a clear direction
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 26.6d old
Duplicates
1 consolidated
#5Not directional
Market sourceDirect company coverageScored from headline

Q2 Earnings Highlights: ICU Medical (NASDAQ:ICUI) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

Published
24 Aug 2026 18:33
News subject
Earnings
Why this score
The headline reports news without a clear direction
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 26.9d old
Duplicates
1 consolidated

Earlier company news

ICU news archive

84 older headlines

Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.

Older news is kept in the archive

There are 84 older ICU headlines. Open one page at a time when you need them.

Open older archive

Provider matches checked

Provider mentions not used in the score

Showing 1-2 of 2

A news provider linked these stories to ICU, but the headline and available text are not mainly about SeaStar Medical Holding Corporation. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.

How the page works

How to read the score

The score shows direction

It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

What the page does

It measures news already published. It is not a forecast, recommendation or price target.

Evidence context